On the public citation graph

Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs

0 signed · 76 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cmdc.201000272openalex-snapshot

Structural and Potency Relationships between Scaffolds of Compounds Active against Human Targets

inferredcites →https://doi.org/10.1016/j.cbpa.2008.01.044openalex-snapshot

Computational analysis of ligand relationships within target families

inferredcites →https://doi.org/10.1016/j.cbpa.2010.06.166openalex-snapshot

Rational approaches to targeted polypharmacology: creating and navigating protein–ligand interaction networks

inferredcites →https://doi.org/10.1016/j.drudis.2009.02.010openalex-snapshot

A chemogenomic approach to drug discovery: focus on cardiovascular diseases

inferredcites →https://doi.org/10.1016/j.tips.2009.07.004openalex-snapshot

Conciliating binding efficiency and polypharmacology

inferredcites →https://doi.org/10.1021/ci00057a005openalex-snapshot

SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules

inferredcites →https://doi.org/10.1021/ci100059qopenalex-snapshot

Molecular Scaffolds with High Propensity to Form Multi-Target Activity Cliffs

inferredcites →https://doi.org/10.1021/jm00120a002openalex-snapshot

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

inferredcites →https://doi.org/10.1021/jm901132vopenalex-snapshot

Selectively Nonselective Kinase Inhibition: Striking the Right Balance

inferredcites →https://doi.org/10.1021/jm9014229openalex-snapshot

Systematic Analysis of Public Domain Compound Potency Data Identifies Selective Molecular Scaffolds across Druggable Target Families

inferredcites →https://doi.org/10.1021/jm9602928openalex-snapshot

The Properties of Known Drugs. 1. Molecular Frameworks

inferredcites →https://doi.org/10.1038/nature08506openalex-snapshot

Predicting new molecular targets for known drugs

inferredcites →https://doi.org/10.1038/nbt1228openalex-snapshot

Global mapping of pharmacological space

inferredcites →https://doi.org/10.1038/nbt1284openalex-snapshot

Relating protein pharmacology by ligand chemistry

inferredcites →https://doi.org/10.1038/nbt1358openalex-snapshot

A quantitative analysis of kinase inhibitor selectivity

inferredcites →https://doi.org/10.1038/nchembio.118openalex-snapshot

Network pharmacology: the next paradigm in drug discovery

inferredcites →https://doi.org/10.1093/nar/gkm958openalex-snapshot

DrugBank: a knowledgebase for drugs, drug actions and drug targets

inferredcites →https://doi.org/10.1101/gr.1239303openalex-snapshot

Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9781118778166.ch6openalex-snapshot

A Perspective on the Evolution of Collaborative Drug Discovery and Future Challenges

inferred← citeshttps://doi.org/10.1002/9783527665143.ch03openalex-snapshot

Scaffold Diversity in Medicinal Chemistry Space

inferred← citeshttps://doi.org/10.1002/9783527665143.ch04openalex-snapshot

Scaffold Mining of Publicly Available Compound Data

inferred← citeshttps://doi.org/10.1002/ddr.22125openalex-snapshot

Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development

inferred← citeshttps://doi.org/10.1002/minf.201200120openalex-snapshot

Activity Landscapes, Information Theory, and Structure – Activity Relationships

inferred← citeshttps://doi.org/10.1002/minf.201300044openalex-snapshot

Visualization of Activity Landscapes and Chemogenomics Data

inferred← citeshttps://doi.org/10.1002/minf.201500034openalex-snapshot

Method for Systematic Assessment of Chemical Changes in Molecular Scaffolds with Conserved Topology and Application to the Analysis of Scaffold‐Activity Relationships

inferred← citeshttps://doi.org/10.1002/psp4.25openalex-snapshot

PhIN: A Protein Pharmacology Interaction Network Database

inferred← citeshttps://doi.org/10.1007/978-1-4939-6613-4_14openalex-snapshot

Compound Data Mining for Drug Discovery

inferred← citeshttps://doi.org/10.1007/978-3-030-05282-9_2openalex-snapshot

Pharmacophore Modelling and Screening: Concepts, Recent Developments and Applications in Rational Drug Design

inferred← citeshttps://doi.org/10.1007/978-3-030-32857-3_3openalex-snapshot

The Efficiency of Multi-target Drugs: A Network Approach

inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_14openalex-snapshot

Polypharmacology in Predicting Drug Toxicity: Drug Promiscuity

inferred← citeshttps://doi.org/10.1007/s11095-011-0486-6openalex-snapshot

Finding Promiscuous Old Drugs for New Uses

inferred← citeshttps://doi.org/10.1007/s12325-018-0778-xopenalex-snapshot

Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’

inferred← citeshttps://doi.org/10.1016/b978-0-12-385944-0.00008-3openalex-snapshot

Chemogenomic Profiling

inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00021-3openalex-snapshot

In Silico Modeling of FDA-Approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach

inferred← citeshttps://doi.org/10.1016/b978-0-323-99137-7.00011-3openalex-snapshot

Alternative biological screening methods

inferred← citeshttps://doi.org/10.1016/b978-1-60805-979-9.50009-3openalex-snapshot

Data Quality Assurance and Statistical Analysis of High Throughput Screenings for Drug Discovery

inferred← citeshttps://doi.org/10.1016/j.bbapap.2013.05.010openalex-snapshot

Cheminformatics at the interface of medicinal chemistry and proteomics

inferred← citeshttps://doi.org/10.1016/j.csbj.2018.11.002openalex-snapshot

YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery

inferred← citeshttps://doi.org/10.1016/j.drudis.2011.08.002openalex-snapshot

The role of fragment-based and computational methods in polypharmacology

inferred← citeshttps://doi.org/10.1016/j.drudis.2012.11.008openalex-snapshot

The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so

inferred← citeshttps://doi.org/10.1016/j.drudis.2013.03.002openalex-snapshot

Compound promiscuity: what can we learn from current data?

inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.02.040openalex-snapshot

Many drugs contain unique scaffolds with varying structural relationships to scaffolds of currently available bioactive compounds

inferred← citeshttps://doi.org/10.1016/j.pbiomolbio.2016.08.006openalex-snapshot

Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting

inferred← citeshttps://doi.org/10.1016/j.pharmthera.2013.01.016openalex-snapshot

Structure and dynamics of molecular networks: A novel paradigm of drug discovery

inferred← citeshttps://doi.org/10.1016/j.vascn.2013.01.004openalex-snapshot

Troubleshooting and deconvoluting label-free cell phenotypic assays in drug discovery

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01787openalex-snapshot

Matched Molecular Pair Analysis in Drug Discovery: Methods and Recent Applications

inferred← citeshttps://doi.org/10.1021/acsptsci.5c00430openalex-snapshot

Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets

inferred← citeshttps://doi.org/10.1021/bk-2016-1222.ch004openalex-snapshot

Network Variants for Analyzing Target-Ligand Interactions

inferred← citeshttps://doi.org/10.1021/ci200179yopenalex-snapshot

Lessons Learned from Molecular Scaffold Analysis

inferred← citeshttps://doi.org/10.1021/ci200461wopenalex-snapshot

Target Family-Directed Exploration of Scaffolds with Different SAR Profiles

inferred← citeshttps://doi.org/10.1021/ci300005yopenalex-snapshot

Chemical and Biological Properties of Frequent Screening Hits

inferred← citeshttps://doi.org/10.1021/ci3003304openalex-snapshot

Growth of Ligand–Target Interaction Data in ChEMBL Is Associated with Increasing and Activity Measurement-Dependent Compound Promiscuity

inferred← citeshttps://doi.org/10.1021/ci300616sopenalex-snapshot

Systematic Identification of Scaffolds Representing Compounds Active against Individual Targets and Single or Multiple Target Families

inferred← citeshttps://doi.org/10.1021/jm301292aopenalex-snapshot

Matched Molecular Pair Analysis of Small Molecule Microarray Data Identifies Promiscuity Cliffs and Reveals Molecular Origins of Extreme Compound Promiscuity

inferred← citeshttps://doi.org/10.1021/jm5006463openalex-snapshot

Polypharmacology: Challenges and Opportunities in Drug Discovery

inferred← citeshttps://doi.org/10.1038/s41570-024-00593-3openalex-snapshot

Tackling assay interference associated with small molecules

inferred← citeshttps://doi.org/10.1039/c2md00302copenalex-snapshot

Structural enrichment of HTS compounds from available commercial libraries

inferred← citeshttps://doi.org/10.1080/17460441.2019.1613368openalex-snapshot

Quantitative structure–activity relationship models for compounds with anticonvulsant activity

inferred← citeshttps://doi.org/10.1080/17460441.2020.1767063openalex-snapshot

An up-to-date overview of computational polypharmacology in modern drug discovery

inferred← citeshttps://doi.org/10.1101/044289openalex-snapshot

Structural and Functional View of Polypharmacology

inferred← citeshttps://doi.org/10.1101/054734openalex-snapshot

Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting

inferred← citeshttps://doi.org/10.1111/cbdd.12162openalex-snapshot

Toward an Efficient Approach to Identify Molecular Scaffolds Possessing Selective or Promiscuous Compounds

inferred← citeshttps://doi.org/10.1111/febs.12268openalex-snapshot

Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it

inferred← citeshttps://doi.org/10.1186/s13321-016-0137-3openalex-snapshot

Badapple: promiscuity patterns from noisy evidence

inferred← citeshttps://doi.org/10.1186/s13321-019-0370-7openalex-snapshot

Bioactivity-explorer: a web application for interactive visualization and exploration of bioactivity data

inferred← citeshttps://doi.org/10.1208/s12248-012-9392-zopenalex-snapshot

Rationalizing Structure and Target Relationships between Current Drugs

inferred← citeshttps://doi.org/10.1208/s12248-012-9421-yopenalex-snapshot

How Promiscuous Are Pharmaceutically Relevant Compounds? A Data-Driven Assessment

inferred← citeshttps://doi.org/10.1208/s12248-014-9621-8openalex-snapshot

Many Approved Drugs Have Bioactive Analogs With Different Target Annotations

inferred← citeshttps://doi.org/10.1517/14656566.2012.696097openalex-snapshot

Mechanistic and functional differentiation of tapentadol and tramadol

inferred← citeshttps://doi.org/10.2147/jrlcr.s46843openalex-snapshot

Pharmacophore modeling: advances, limitations, and current utility in drug discovery

inferred← citeshttps://doi.org/10.2174/15680266113139990028openalex-snapshot

Recent Trends and Future Prospects in Computational GPCR Drug Discovery: From Virtual Screening to Polypharmacology

inferred← citeshttps://doi.org/10.2174/157016461103140922164228openalex-snapshot

Oncogenic Signalling Networks and Polypharmacology as Paradigms to Cope with Cancer Heterogeneity

inferred← citeshttps://doi.org/10.3389/fphar.2024.1419110openalex-snapshot

Medicinal polypharmacology—a scientific glossary of terminology and concepts

inferred← citeshttps://doi.org/10.4155/fmc.11.16openalex-snapshot

Connecting the Virtual World of Computers to the Real World of Medicinal Chemistry

inferred← citeshttps://doi.org/10.4155/fmc.13.208openalex-snapshot

Improving Data Mining Strategies for Drug Design

inferred← citeshttps://doi.org/10.52711/0974-360x.2023.00246openalex-snapshot

An Overview on Pharmacophore: Their significance and importance for the activity of Drug Design

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.